Bretscher P
Cancers (Basel). 2024; 16(7).
PMID: 38611110
PMC: 11010850.
DOI: 10.3390/cancers16071431.
Bretscher P
Biology (Basel). 2023; 12(9).
PMID: 37759652
PMC: 10525557.
DOI: 10.3390/biology12091253.
Gautam S, Batra S, Jain M
Mol Cancer. 2023; 22(1):118.
PMID: 37488598
PMC: 10367391.
DOI: 10.1186/s12943-023-01813-y.
Mercier R, LaPointe P
J Biol Chem. 2022; 298(5):101930.
PMID: 35421375
PMC: 9108985.
DOI: 10.1016/j.jbc.2022.101930.
Alicke B, Totpal K, Schartner J, Berkley A, Lehar S, Capietto A
J Immunother Cancer. 2020; 8(2).
PMID: 32675310
PMC: 7368499.
DOI: 10.1136/jitc-2020-000532.
Characterization of a Novel Murine Colon Carcinoma Subline with High-Metastatic Activity Established by In Vivo Selection Method.
Ma L, Sakamoto Y, Kanai A, Otsuka H, Takahashi A, Kakimi K
Int J Mol Sci. 2020; 21(8).
PMID: 32325684
PMC: 7215277.
DOI: 10.3390/ijms21082829.
On Analyzing How the Th1/Th2 Phenotype of an Immune Response Is Determined: Classical Observations Must Not Be Ignored.
Bretscher P
Front Immunol. 2019; 10:1234.
PMID: 31231378
PMC: 6560152.
DOI: 10.3389/fimmu.2019.01234.
Tumour devascularisation as a potential immunotherapeutic strategy.
Buchler T, Vasek P, Spisek R, Skrobanek P, Horejsi V
Oncoimmunology. 2018; 8(1):e1526614.
PMID: 30546967
PMC: 6287775.
DOI: 10.1080/2162402X.2018.1526614.
The immune system in cancer metastasis: friend or foe?.
Janssen L, Ramsay E, Logsdon C, Overwijk W
J Immunother Cancer. 2017; 5(1):79.
PMID: 29037250
PMC: 5644253.
DOI: 10.1186/s40425-017-0283-9.
Primary melanoma tumor inhibits metastasis through alterations in systemic hemostasis.
Kirstein J, Hague M, McGowan P, Tuck A, Chambers A
J Mol Med (Berl). 2016; 94(8):899-910.
PMID: 27048169
DOI: 10.1007/s00109-016-1415-2.
A "universal" model of metastatic cancer, its parametric forms and their identification: what can be learned from site-specific volumes of metastases.
Hanin L, Seidel K, Stoevesandt D
J Math Biol. 2015; 72(6):1633-62.
PMID: 26307099
DOI: 10.1007/s00285-015-0928-6.
Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance.
Willimsky G, Schmidt K, Loddenkemper C, Gellermann J, Blankenstein T
J Clin Invest. 2013; 123(3):1032-43.
PMID: 23454765
PMC: 3582129.
DOI: 10.1172/JCI64742.
Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade.
Pilones K, Kawashima N, Yang A, Babb J, Formenti S, Demaria S
Clin Cancer Res. 2009; 15(2):597-606.
PMID: 19147765
PMC: 2730222.
DOI: 10.1158/1078-0432.CCR-08-1277.
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness.
Willimsky G, Czeh M, Loddenkemper C, Gellermann J, Schmidt K, Wust P
J Exp Med. 2008; 205(7):1687-700.
PMID: 18573907
PMC: 2442645.
DOI: 10.1084/jem.20072016.
Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancer.
Hamilton D, Bretscher P
Cancer Immunol Immunother. 2008; 57(8):1125-36.
PMID: 18188562
PMC: 11029879.
DOI: 10.1007/s00262-007-0442-9.
Anti-inflammatory pretreatment enables an efficient dendritic cell-based immunotherapy against established tumors.
Chiarella P, Vulcano M, Bruzzo J, Vermeulen M, Vanzulli S, Maglioco A
Cancer Immunol Immunother. 2007; 57(5):701-18.
PMID: 17962945
PMC: 11030084.
DOI: 10.1007/s00262-007-0410-4.
The biological sense of cancer: a hypothesis.
Ruggiero R, Bustuoabad O
Theor Biol Med Model. 2006; 3:43.
PMID: 17173673
PMC: 1764731.
DOI: 10.1186/1742-4682-3-43.
Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors.
Yu P, Lee Y, Liu W, Krausz T, Chong A, Schreiber H
J Exp Med. 2005; 201(5):779-91.
PMID: 15753211
PMC: 2212829.
DOI: 10.1084/jem.20041684.
Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells.
Turk M, Guevara-Patino J, Rizzuto G, Engelhorn M, Sakaguchi S, Houghton A
J Exp Med. 2004; 200(6):771-82.
PMID: 15381730
PMC: 2211964.
DOI: 10.1084/jem.20041130.
Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistance.
Scharovsky O, Binda M, Rozados V, Bhagat S, Cher M, Bonfil R
Clin Exp Metastasis. 2004; 21(2):177-83.
PMID: 15168735
DOI: 10.1023/b:clin.0000024762.32172.13.
